Ontrak (OTRK) Competitors

Ontrak (NASDAQ:OTRK) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, community ranking, profitability and media sentiment.

Does the media favor OTRK or ENZ?

In the previous week, Ontrak had 1 more articles in the media than Enzo Biochem. MarketBeat recorded 1 mentions for Ontrak and 0 mentions for Enzo Biochem. Ontrak's average media sentiment score of 1.87 beat Enzo Biochem's score of 0.00 indicating that Ontrak is being referred to more favorably in the media.

Company	Overall Sentiment
Ontrak	Very Positive
Enzo Biochem	Neutral

Does the MarketBeat Community favor OTRK or ENZ?

Enzo Biochem received 174 more outperform votes than Ontrak when rated by MarketBeat users. However, 59.38% of users gave Ontrak an outperform vote while only 53.54% of users gave Enzo Biochem an outperform vote.

Company	Underperform	Outperform
Ontrak	Outperform Votes 38 59.38%	Underperform Votes 26 40.63%
Enzo Biochem	Outperform Votes 212 53.54%	Underperform Votes 184 46.46%

Which has higher valuation and earnings, OTRK or ENZ?

Enzo Biochem has higher revenue and earnings than Ontrak.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ontrak	$11.24M	0.54	-$27.92M	-$10.62	-0.14
Enzo Biochem	$30.31M	0.85	-$26.08M	N/A	N/A

Which has more risk & volatility, OTRK or ENZ?

Ontrak has a beta of 2.54, meaning that its share price is 154% more volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500.

Do institutionals & insiders hold more shares of OTRK or ENZ?

12.9% of Ontrak shares are held by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are held by institutional investors. 1.9% of Ontrak shares are held by insiders. Comparatively, 11.4% of Enzo Biochem shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Is OTRK or ENZ more profitable?

Enzo Biochem has a net margin of -75.34% compared to Ontrak's net margin of -237.77%. Enzo Biochem's return on equity of -7.96% beat Ontrak's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ontrak	-237.77%	-171.34%	-113.42%
Enzo Biochem	-75.34%	-7.96%	-5.49%

Do analysts rate OTRK or ENZ?

Ontrak currently has a consensus price target of $45.00, indicating a potential upside of 3,035.89%. Given Ontrak's stronger consensus rating and higher probable upside, equities research analysts clearly believe Ontrak is more favorable than Enzo Biochem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ontrak	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Enzo Biochem	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Enzo Biochem beats Ontrak on 9 of the 16 factors compared between the two stocks.